SI3256138T1 - Farmacevtski sestavki, ki obsegajo meloksikam - Google Patents

Farmacevtski sestavki, ki obsegajo meloksikam

Info

Publication number
SI3256138T1
SI3256138T1 SI201631525T SI201631525T SI3256138T1 SI 3256138 T1 SI3256138 T1 SI 3256138T1 SI 201631525 T SI201631525 T SI 201631525T SI 201631525 T SI201631525 T SI 201631525T SI 3256138 T1 SI3256138 T1 SI 3256138T1
Authority
SI
Slovenia
Prior art keywords
meloxicam
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
SI201631525T
Other languages
English (en)
Inventor
Herriot Tabuteau
Original Assignee
Axsome Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axsome Therapeutics, Inc. filed Critical Axsome Therapeutics, Inc.
Priority claimed from PCT/US2016/026991 external-priority patent/WO2016131067A2/en
Publication of SI3256138T1 publication Critical patent/SI3256138T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
SI201631525T 2015-11-25 2016-04-11 Farmacevtski sestavki, ki obsegajo meloksikam SI3256138T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562259993P 2015-11-25 2015-11-25
EP16750078.4A EP3256138B1 (en) 2015-11-25 2016-04-11 Pharmaceutical compositions comprising meloxicam
PCT/US2016/026991 WO2016131067A2 (en) 2015-02-10 2016-04-11 Pharmaceutical compositions comprising meloxicam

Publications (1)

Publication Number Publication Date
SI3256138T1 true SI3256138T1 (sl) 2022-07-29

Family

ID=60389519

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201631525T SI3256138T1 (sl) 2015-11-25 2016-04-11 Farmacevtski sestavki, ki obsegajo meloksikam

Country Status (14)

Country Link
EP (2) EP4008319A1 (sl)
JP (5) JP6746612B2 (sl)
KR (2) KR102447080B1 (sl)
CN (2) CN107405359B (sl)
CA (1) CA3204396A1 (sl)
DK (1) DK3256138T3 (sl)
ES (1) ES2913288T3 (sl)
HK (1) HK1243650A1 (sl)
HU (1) HUE058677T2 (sl)
LT (1) LT3256138T (sl)
MX (2) MX2017010304A (sl)
PL (1) PL3256138T3 (sl)
RS (1) RS63260B1 (sl)
SI (1) SI3256138T1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102447080B1 (ko) * 2015-11-25 2022-09-23 액섬 테라퓨틱스, 인크. 멜록시캄을 포함하는 약학 조성물
EP3920909A4 (en) 2019-02-06 2022-11-30 Axsome Therapeutics, Inc. PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005199A1 (de) 1994-08-12 1996-02-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridinsalz
AU688087B2 (en) 1994-08-13 1998-03-05 Yuhan Corporation Novel pyrimidine derivatives and processes for the preparation thereof
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
NZ502990A (en) * 1997-08-27 2002-02-01 Hexal Ag Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
MXPA03011017A (es) * 2001-06-01 2005-04-29 Pozen Inc Composiciones farmaceuticas para la entrega coordinada de nsaids.
GB0320382D0 (en) * 2003-08-30 2003-10-01 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Pharmaceutical compositions
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
CA2565941A1 (en) * 2004-05-04 2005-11-10 Equitech Corporation Improved nsaid composition
US20070154542A1 (en) * 2005-12-30 2007-07-05 Cogentus Pharmaceuticals, Inc. Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
AU2008206231A1 (en) * 2007-01-19 2008-07-24 Takeda Pharmaceuticals U.S.A., Inc. Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents
KR20160033792A (ko) * 2007-04-27 2016-03-28 사이덱스 파마슈티칼스, 인크. 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
NZ599643A (en) * 2007-06-20 2013-11-29 Auspex Pharmaceuticals Inc Substituted N-aryl pyridinones as fibrotic inhibitors
US8236782B2 (en) * 2009-05-13 2012-08-07 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
WO2012054831A2 (en) * 2010-10-21 2012-04-26 Rtu Pharmaceuticals, Llc Ready to use ketorolac formulations
CN102526058A (zh) * 2010-12-28 2012-07-04 秦引林 一种含氯诺昔康和埃索美拉唑消炎镇痛药物组合物
WO2014161131A1 (en) * 2013-04-01 2014-10-09 Arissa Pharma PREPARING AMORPHOUS MELOXICAM-β-CYCLODEXTRIN INCLUSION COMPLEX VIA SPRAY DRYING PROCESS
KR102447080B1 (ko) * 2015-11-25 2022-09-23 액섬 테라퓨틱스, 인크. 멜록시캄을 포함하는 약학 조성물

Also Published As

Publication number Publication date
KR102429352B1 (ko) 2022-08-03
JP2021066749A (ja) 2021-04-30
EP3256138A2 (en) 2017-12-20
JP6842122B2 (ja) 2021-03-17
JP6746612B2 (ja) 2020-08-26
JP7017275B2 (ja) 2022-02-08
KR20220110869A (ko) 2022-08-09
RS63260B1 (sr) 2022-06-30
HK1243650A1 (zh) 2018-07-20
EP3256138B1 (en) 2022-02-23
EP3256138A4 (en) 2019-10-02
MX2021003230A (es) 2022-08-18
PL3256138T3 (pl) 2022-08-01
JP2019131596A (ja) 2019-08-08
MX2017010304A (es) 2018-06-19
JP2022040370A (ja) 2022-03-10
CN113144218A (zh) 2021-07-23
ES2913288T3 (es) 2022-06-01
CN107405359B (zh) 2021-04-20
DK3256138T3 (da) 2022-05-16
KR20210111333A (ko) 2021-09-10
LT3256138T (lt) 2022-06-10
CN107405359A (zh) 2017-11-28
HUE058677T2 (hu) 2022-09-28
JP7332202B2 (ja) 2023-08-23
KR102447080B1 (ko) 2022-09-23
EP4008319A1 (en) 2022-06-08
CA3204396A1 (en) 2016-08-18
JP2018508570A (ja) 2018-03-29
JP2023133545A (ja) 2023-09-22

Similar Documents

Publication Publication Date Title
IL281863A (en) Preparations containing meloxicam
PT3565550T (pt) Composições farmacêuticas compreendendo meloxicam e rizatriptano
HK1225655A1 (zh) 包含azd9291的藥用組合物
GB201618482D0 (en) Pharmaceutical compositions
GB201419257D0 (en) Pharmaceutical compositions
IL249553A0 (en) Pharmaceutical preparations
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201521462D0 (en) Pharmaceutical composition
HK1250491A1 (zh) 穩定化的醫藥組合物
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (zh) 藥物組合物
IL250817A0 (en) pharmaceutical preparations
GB201520862D0 (en) Pharmaceutical composition
HK1243650A1 (zh) 包含美洛昔康的藥物組合物
PT3200772T (pt) Composições farmacêuticas compreendendo alpelisib
PL3424500T3 (pl) Kompozycja farmaceutyczna zawierająca famitynib
HRP20220610T8 (hr) Farmaceutski pripravci koji sadrže meloksikam
PT3319596T (pt) Composições farmacêuticas
GB201521456D0 (en) Pharmaceutical composition
GB201506598D0 (en) Pharmaceutical compositions
GB201520762D0 (en) Novel pharmaceutical compositions
SG2014014872A (en) Pharmaceutical compositions
GB201408432D0 (en) Pharmaceutical compositions